Filtered By:
Condition: Ischemic Stroke
Drug: Aspirin
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 2045 results found since Jan 2013.
Capsular warning syndrome and its clinical awareness and therapeutic approach: two case reports and a systematic review of the literature
ConclusionOur cases fit with the description of patients with partial recovery and risk factors (hypertension, diabetes, and smoking) in male patients. There is a lack of evidence regarding the best treatment option; dual antiplatelet therapy and anticoagulation therapy are strong contenders for a favorable result.
Source: Frontiers in Neurology - May 16, 2023 Category: Neurology Source Type: research
Tirofiban in the treatment of cancer-associated ischemic stroke
CONCLUSIONS: Early administration of tirofiban in the treatment of mild to moderate ischemic stroke is safe, which can reduce 24-hour and 7-day NIHSS scores and has potential value.PMID:37140310 | DOI:10.26355/eurrev_202304_32142
Source: Pharmacological Reviews - May 4, 2023 Category: Drugs & Pharmacology Authors: Z-M Zhang Z-H Lin G-L Zhu Source Type: research
Efficacy and Prognosis of Adjuvant Argatroban Treatment in Acute Ischemic Stroke Patients with Early Neurological Deterioration
CONCLUSIONS: Aspirin combined with argatroban significantly improved neurological impairment of AIS patients with END, which is worthy of clinical application.PMID:37105928 | DOI:10.24976/Discov.Med.202335175.19
Source: Discovery Medicine - April 27, 2023 Category: Research Authors: Shu Xu Wenjun Zhang Yan Zhang Zhou Xu Ting Wu Source Type: research
